542 related articles for article (PubMed ID: 22781041)
41. [Analysis of lymph node metastasis in the thoracic esophageal squamous cell carcinoma].
Zhu ZJ; Zhao YF; Hu Y; Chen LQ; Liu LX; Wu Z; Kou YL; Wang Y
Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):138-40. PubMed ID: 18646699
[TBL] [Abstract][Full Text] [Related]
42. Comparison of efficacy of regional and extensive clinical target volumes in postoperative radiotherapy for esophageal squamous cell carcinoma.
Qiao XY; Wang W; Zhou ZG; Gao XS; Chang JY
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):396-402. PubMed ID: 17855004
[TBL] [Abstract][Full Text] [Related]
43. [Lymphatic metastasis intensity of and lymphadenectomy for thoracic esophageal squamous cell carcinoma].
Lu ZM; Zhang H; Wang MH; Cui DH; Yang YQ; Huang HZ
Ai Zheng; 2006 May; 25(5):604-8. PubMed ID: 16687083
[TBL] [Abstract][Full Text] [Related]
44. [Analysis of lymph node metastases in early esophageal carcinoma and treatment regimens].
Li L; Liu SY; Zhu KS; Chen JQ; Ying MG
Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):226-9. PubMed ID: 19615267
[TBL] [Abstract][Full Text] [Related]
45. The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation.
Gu Y; Swisher SG; Ajani JA; Correa AM; Hofstetter WL; Liao Z; Komaki RR; Rashid A; Hamilton SR; Wu TT
Cancer; 2006 Mar; 106(5):1017-25. PubMed ID: 16456809
[TBL] [Abstract][Full Text] [Related]
46. [Influence of the number of lymph node metastasis on survival and significance of postoperative radiotherapy for esophageal carcinoma].
Xiao ZF; Yang ZY; Wang LH; Zhang HX; Feng QF; Chen DF; Zhou ZM; Zhang DC; Sun KL; Cheng GY; He J
Zhonghua Zhong Liu Za Zhi; 2004 Feb; 26(2):112-5. PubMed ID: 15059333
[TBL] [Abstract][Full Text] [Related]
47. [The patterns and prognostic factors of abdominal lymph node metastasis in patients with the middle thoracic esophageal squamous cell carcinoma].
Wang Z; Liu XY; Liu FY
Zhonghua Wai Ke Za Zhi; 2008 Dec; 46(23):1800-3. PubMed ID: 19094790
[TBL] [Abstract][Full Text] [Related]
48. [Clinical analysis of 126 patients with primary small cell carcinoma of the esophagus].
Lü JM; Liang J; Wang JW; He J; Xiao ZF; Zhang HX; Chen DF; Feng QF; Wang LH
Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):121-5. PubMed ID: 19538888
[TBL] [Abstract][Full Text] [Related]
49. [Regulations and lymphadenectomy strategy of mediastinal and upper abdominal lymph node metastasis in thoracic esophageal carcinoma].
Xue HC; Wu CR; Zhang ZB; Zhu ZH; Ma ZK; Gao J
Ai Zheng; 2007 Sep; 26(9):1020-4. PubMed ID: 17927865
[TBL] [Abstract][Full Text] [Related]
50. [VEGF-C mRNA expression and its relationship with clinicopathological parameters in esophageal squamous cell carcinoma].
Pan XF; Bao GL; Fang WT; Chen WH
Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):437-40. PubMed ID: 19024518
[TBL] [Abstract][Full Text] [Related]
51. Staging of esophageal carcinoma: length of tumor and number of involved regional lymph nodes. Are these independent prognostic factors?
Bollschweiler E; Baldus SE; Schröder W; Schneider PM; Hölscher AH
J Surg Oncol; 2006 Oct; 94(5):355-63. PubMed ID: 16967455
[TBL] [Abstract][Full Text] [Related]
52. Total number of resected lymph nodes predicts survival in esophageal cancer.
Altorki NK; Zhou XK; Stiles B; Port JL; Paul S; Lee PC; Mazumdar M
Ann Surg; 2008 Aug; 248(2):221-6. PubMed ID: 18650631
[TBL] [Abstract][Full Text] [Related]
53. Lymph node dissection for thoracic esophageal carcinoma. Two- and 3-field lymph node dissection.
Kato H
Ann Chir Gynaecol; 1995; 84(2):193-9. PubMed ID: 7574380
[TBL] [Abstract][Full Text] [Related]
54. Pathologic prognostic factors in esophageal squamous cell carcinoma: a follow-up study of 74 patients with or without preoperative chemoradiation therapy.
Torres CM; Wang HH; Turner JR; Richards W; Sugarbaker D; Shahsafaei A; Odze RD
Mod Pathol; 1999 Oct; 12(10):961-8. PubMed ID: 10530561
[TBL] [Abstract][Full Text] [Related]
55. [Ivor Lewis esophagectomy with two-field lymph node dissection for squamous cell carcinoma of the lower thoracic esophagus].
Wu J; Chai Y; Zhou XM; Chen QX; Yan FL
Ai Zheng; 2007 Mar; 26(3):307-11. PubMed ID: 17355797
[TBL] [Abstract][Full Text] [Related]
56. Improving the accuracy of TNM staging in esophageal cancer: a pathological review of resected specimens.
Thompson SK; Ruszkiewicz AR; Jamieson GG; Esterman A; Watson DI; Wijnhoven BP; Lamb PJ; Devitt PG
Ann Surg Oncol; 2008 Dec; 15(12):3447-58. PubMed ID: 18830669
[TBL] [Abstract][Full Text] [Related]
57. Prognostic analysis of the patients with stage-III esophageal squamous cell carcinoma after radical esophagectomy.
Hu Y; Zheng B; Rong TH; Fu JH; Zhu ZH; Yang H; Luo KJ; Li YF
Chin J Cancer; 2010 Feb; 29(2):178-83. PubMed ID: 20109347
[TBL] [Abstract][Full Text] [Related]
58. Prognostic significance of perioperative blood transfusions in resectable thoracic esophageal cancer.
Tachibana M; Tabara H; Kotoh T; Kinugasa S; Dhar DK; Hishikawa Y; Masunaga R; Kubota H; Nagasue N
Am J Gastroenterol; 1999 Mar; 94(3):757-65. PubMed ID: 10086663
[TBL] [Abstract][Full Text] [Related]
59. Esophagectomy with extended lymphadenectomy for submucosal esophageal cancer: long-term outcomes and prognostic factors.
Tanaka T; Matono S; Nagano T; Shirouzu K; Fujita H; Yamana H
Ann Surg Oncol; 2012 Mar; 19(3):750-6. PubMed ID: 21861216
[TBL] [Abstract][Full Text] [Related]
60. Survival after esophageal resection for carcinoma: the importance of the histologic cell type.
Alexiou C; Khan OA; Black E; Field ML; Onyeaka P; Beggs L; Duffy JP; Beggs DF
Ann Thorac Surg; 2006 Sep; 82(3):1073-7. PubMed ID: 16928541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]